| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/HYPERTENSIONAHA.110.168245 |
| P698 | PubMed publication ID | 21518967 |
| P50 | author | Christodoulos I. Stefanadis | Q17308889 |
| Alexios S. Antonopoulos | Q48174081 | ||
| Constantinos Bakogiannis | Q59821554 | ||
| Charalambos Vlachopoulos | Q88459731 | ||
| Charalambos Antoniades | Q89090660 | ||
| Dimitris Tousoulis | Q90167660 | ||
| George Lazaros | Q98781854 | ||
| Marina Toutouza | Q114563313 | ||
| Kyriakoula Marinou | Q114563429 | ||
| Costas Triantafyllou | Q125324259 | ||
| Nikolaos Koumallos | Q125326731 | ||
| P2093 | author name string | Michael Koutsilieris | |
| Michael Demosthenous | |||
| Dimitris Lymperiadis | |||
| Kleio Mavragani | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| endothelium | Q111140 | ||
| inflammation | Q101991 | ||
| P304 | page(s) | 93-98 | |
| P577 | publication date | 2011-04-25 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis | |
| P478 | volume | 58 |
| Q38477549 | A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations |
| Q42131252 | ADMA, SDMA and L-arginine may be Novel Targets in Pharmacotherapy for Complications due to Cardiopulmonary Bypass |
| Q37297560 | Analysis of gene expression profile identifies potential biomarkers for atherosclerosis |
| Q90162945 | Arginine Derivatives in Cerebrovascular Diseases: Mechanisms and Clinical Implications |
| Q36498512 | Association of dimethylarginines and mediators of inflammation after acute ischemic stroke |
| Q47107685 | Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol |
| Q37710176 | Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association? |
| Q26795604 | Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis |
| Q42769487 | Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease |
| Q35597501 | Caffeic acid, a phenol found in white wine, modulates endothelial nitric oxide production and protects from oxidative stress-associated endothelial cell injury. |
| Q37695181 | Ciliotherapy: a novel intervention in polycystic kidney disease |
| Q90220350 | Decline of popliteal artery flow-mediated dilation with aging and possible involvement of asymmetric dimethylarginine in healthy men |
| Q47654398 | Does cardiac resynchronization therapy restore peripheral circulatory homeostasis? |
| Q59798063 | Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia |
| Q35153847 | Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice |
| Q37597536 | Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients. |
| Q46265148 | Elevated Levels of ADMA Are Associated with Lower DDAH2 and Higher PRMT1 in LPS-Induced Endometritis Rats |
| Q38680112 | Endothelial dysfunction and vascular disease - a 30th anniversary update |
| Q34072179 | Endothelial dysfunction in chronic inflammatory diseases |
| Q38745381 | Glucocorticoid-induced fetal origins of adult hypertension: Association with epigenetic events |
| Q36596023 | Insulin resistance, endothelial function, angiogenic factors and clinical outcome in non-diabetic patients with chest pain without myocardial perfusion defects |
| Q64097648 | Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases |
| Q41407607 | Oxidized low-density lipoprotein decreases VEGFR2 expression in HUVECs and impairs angiogenesis |
| Q38629539 | Renin-Angiotensin system inhibitors reduce serum asymmetric dimethylarginine levels and oxidative stress in normotensive patients with chronic kidney disease |
| Q94464751 | Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases |
| Q89395801 | Statins as Pleiotropic Modifiers of Vascular Oxidative Stress and Inflammation |
| Q36088110 | Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. |
| Q26776067 | Statins in Asthma: Potential Beneficial Effects and Limitations |
| Q26774561 | Vascular endothelial dysfunction and pharmacological treatment |
Search more.